June 2015

Introduction

Human Papillomavirus–Associated Head & Neck Cancer

Guest Editor Ryan T. Fitzgerald

Human papillomavirus (HPV) is now recognized as the primary causative factor in a subgroup of epidemiologically and clinically distinct cancers of the head and neck, oropharyngeal squamous cell carcinoma (OPSCC).1,2 The rising incidence of OPSCC relative to squamous cell cancers elsewhere … more »

Head & Neck

Fractional Change in Apparent Diffusion Coefficient as an Imaging Biomarker for Predicting Treatment Response in Head and Neck Cancer Treated with Chemoradiotherapy

Munetaka Matoba

Munetaka Matoba

Chemoradiotherapy (CRT) as definitive treatment has become a standard management option for many patients with head-and-neck squamous cell carcinoma (HNSCC), in order to improve the patient’s quality of life via organ preservation. However, the disease control achieved with CRT remains heterogeneous because the treatment … more »

Head & Neck

Improving Imaging Diagnosis of Persistent Nodal Metastases after Definitive Therapy for Oropharyngeal Carcinoma: Specific Signs for CT and Best Performance of Combined Criteria

Jackson Hamilton

With human papillomavirus infection reaching epidemic proportions, oropharyngeal cancers are expected to increase in a younger population than that historically afflicted with head and neck cancer. Because these tumors are most often treated nonsurgically, there is always a debate as to whether nodal … more »